{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T22:40:46Z","timestamp":1782859246846,"version":"3.54.5"},"reference-count":114,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T00:00:00Z","timestamp":1764460800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003125","name":"Suomen Kulttuurirahasto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003125","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010116","name":"Medical Association of Life and Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010116","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010135","name":"Finska L\u00e4kares\u00e4llskapet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010135","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003792","name":"Hj\u00e4rnfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030905","name":"Suomen Parkinson-s\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030905","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004155","name":"Magnus Ehrnroothin S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004155","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004012","name":"Jane ja Aatos Erkon S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004012","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008397","name":"Suomen Tiedeseura","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001658","name":"Minerva Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001658","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, & Immunity - Health"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bbih.2025.101149","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T17:09:41Z","timestamp":1764608981000},"page":"101149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Animal models of Huntington's disease. Pros and cons"],"prefix":"10.1016","volume":"50","author":[{"given":"Polina","family":"Stepanova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merja H.","family":"Voutilainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ove","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Lindholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbih.2025.101149_bib1","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1006\/nbdi.2001.0406","article-title":"Creatine increase survival and delays motor symptoms in a transgenic animal model of Huntington's disease","volume":"8","author":"Andreassen","year":"2001","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbih.2025.101149_bib2","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1006\/nbdi.2002.0562","article-title":"Huntington's disease of the endocrine pancreas: insulin deficiency and diabetes mellitus due to impaired insulin gene expression","volume":"11","author":"Andreassen","year":"2002","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbih.2025.101149_bib3","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/321168a0","article-title":"Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid","volume":"321","author":"Beal","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.bbih.2025.101149_bib4","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1523\/JNEUROSCI.11-06-01649.1991","article-title":"Chronic quinolinic acid lesions in rats closely resemble Huntington's disease","volume":"11","author":"Beal","year":"1991","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbih.2025.101149_bib5","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1523\/JNEUROSCI.13-10-04181.1993","article-title":"Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid","volume":"13","author":"Beal","year":"1993","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbih.2025.101149_bib6","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/j.1471-4159.1993.tb03633.x","article-title":"Age-dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate","volume":"61","author":"Beal","year":"1993","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbih.2025.101149_bib7","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/hmg\/ddi053","article-title":"The R6\/2 transgenic mouse model of Huntington's disease develops diabetes due to deficient beta-cell mass and exocytosis","volume":"14","author":"Bjorkqvist","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbih.2025.101149_bib8","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1084\/jem.20080178","article-title":"A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease","volume":"205","author":"Bjorkqvist","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbih.2025.101149_bib9","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1093\/hmg\/ddn159","article-title":"Sex differences in a transgenic rat model of Huntington's disease: decreased 17beta-estradiol levels correlate with reduced numbers of DARPP32+ neurons in males","volume":"17","author":"Bode","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbih.2025.101149_bib10","doi-asserted-by":"crossref","first-page":"7105","DOI":"10.1073\/pnas.92.15.7105","article-title":"Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates","volume":"92","author":"Brouillet","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbih.2025.101149_bib11","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.bbr.2006.02.028","article-title":"Progressive deterioration of reaction time performance and choreiform symptoms in a new Huntington's disease transgenic ratmodel","volume":"170","author":"Cao","year":"2006","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbih.2025.101149_bib12","doi-asserted-by":"crossref","first-page":"6456","DOI":"10.1523\/JNEUROSCI.0388-12.2012","article-title":"R6\/2 Huntington's disease mice develop early and progressive abnormal brain metabolism and seizures","volume":"32","author":"Cepeda-Prado","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbih.2025.101149_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4137\/IJTR.S2097","article-title":"Kynurenine pathway metabolites in humans: disease and healthy States","volume":"2","author":"Chen","year":"2009","journal-title":"Int. J. Tryptophan Res."},{"key":"10.1016\/j.bbih.2025.101149_bib14","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.bbr.2018.10.036","article-title":"The BACHD rat model of Huntington disease shows slowed learning in a Go\/No-Go-like test of visual discrimination","volume":"359","author":"Clemensson","year":"2019","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbih.2025.101149_bib15","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0306-4522(01)00409-2","article-title":"Essential fatty acids given from conception prevent topographies of motor deficit in a transgenic model of Huntington's disease","volume":"109","author":"Clifford","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbih.2025.101149_bib16","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/263244a0","article-title":"Lesion of striatal neurones with kainic acid provides a model for Huntington's chorea","volume":"263","author":"Coyle","year":"1976","journal-title":"Nature"},{"key":"10.1016\/j.bbih.2025.101149_bib17","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3233\/JHD-130077","article-title":"Corpus callosal atrophy in premanifest and early Huntington's disease","volume":"2","author":"Crawford","year":"2013","journal-title":"J Huntingtons Dis"},{"key":"10.1016\/j.bbih.2025.101149_bib18","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.neuron.2010.12.035","article-title":"Huntington's disease: can mice lead the way to treatment?","volume":"69","author":"Crook","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.bbih.2025.101149_bib19","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","article-title":"Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation","volume":"90","author":"Davies","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.bbih.2025.101149_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006846","article-title":"Elimination of huntingtin in the adult mouse leads to progressive behavioral deficits, bilateral thalamic calcification, and altered brain iron homeostasis","volume":"13","author":"Dietrich","year":"2017","journal-title":"PLoS Genet."},{"key":"10.1016\/j.bbih.2025.101149_bib21","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/81593","article-title":"Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice","volume":"26","author":"Dragatsis","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbih.2025.101149_bib22","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1126\/science.7618107","article-title":"Inactivation of the mouse Huntington's disease gene homolog Hdh","volume":"269","author":"Duyao","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.bbih.2025.101149_bib23","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/096368979700600308","article-title":"Cellular delivery of human CNTF prevents motor and cognitive dysfunction in a rodent model of Huntington's disease","volume":"6","author":"Emerich","year":"1997","journal-title":"Cell Transplant."},{"key":"10.1016\/j.bbih.2025.101149_bib24","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/0014-4886(84)90239-5","article-title":"Studies on the disposition of quinolinic acid after intracerebral or systemic administration in the rat","volume":"84","author":"Foster","year":"1984","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbih.2025.101149_bib25","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.nbd.2011.09.003","article-title":"Age-dependent neurovascular abnormalities and altered microglial morphology in the YAC128 mouse model of Huntington disease","volume":"45","author":"Franciosi","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbih.2025.101149_bib26","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1006\/exnr.1996.0054","article-title":"Behavioral characterization of quinolinate-induced lesions of the medial striatum: relevance for Huntington's disease","volume":"138","author":"Furtado","year":"1996","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbih.2025.101149_bib27","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s10334-019-00742-6","article-title":"Detection of axonal degeneration in a mouse model of Huntington's disease: comparison between diffusion tensor imaging and anomalous diffusion metrics","volume":"32","author":"Gatto","year":"2019","journal-title":"Magma"},{"key":"10.1016\/j.bbih.2025.101149_bib28","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.neurobiolaging.2021.02.006","article-title":"Evaluation of early microstructural changes in the R6\/1 mouse model of Huntington's disease by ultra-high field diffusion MR imaging","volume":"102","author":"Gatto","year":"2021","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbih.2025.101149_bib29","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.1523\/JNEUROSCI.0857-08.2008","article-title":"Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice","volume":"28","author":"Gray","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbih.2025.101149_bib30","doi-asserted-by":"crossref","first-page":"1481 e1481","DOI":"10.1016\/j.neurobiolaging.2011.11.030","article-title":"Aberrant heart rate and brainstem brain-derived neurotrophic factor (BDNF) signaling in a mouse model of Huntington's disease","volume":"33","author":"Griffioen","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbih.2025.101149_bib31","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.neuron.2022.01.006","article-title":"Uninterrupted CAG repeat drives striatum-selective transcriptionopathy and nuclear pathogenesis in human Huntingtin BAC mice","volume":"110","author":"Gu","year":"2022","journal-title":"Neuron"},{"key":"10.1016\/j.bbih.2025.101149_bib32","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.nbd.2004.07.006","article-title":"Neostriatal and cortical quinolinate levels are increased in early grade Huntington's disease","volume":"17","author":"Guidetti","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbih.2025.101149_bib33","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.nbd.2006.02.011","article-title":"Elevated brain 3-hydroxykynurenine and quinolinate levels in Huntington disease mice","volume":"23","author":"Guidetti","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbih.2025.101149_bib34","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1111\/j.1742-4658.2012.08485.x","article-title":"Quinolinic acid, the inescapable neurotoxin","volume":"279","author":"Guillemin","year":"2012","journal-title":"FEBS J."},{"key":"10.1016\/j.bbih.2025.101149_bib35","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1046\/j.1471-4159.2001.00498.x","article-title":"Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection","volume":"78","author":"Guillemin","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbih.2025.101149_bib36","series-title":"Adv Exp Med Biol","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-1-4615-0135-0_12","article-title":"Expression of the kynurenine pathway enzymes in human microglia and macrophages","volume":"527","author":"Guillemin","year":"2003"},{"key":"10.1016\/j.bbih.2025.101149_bib37","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/glia.20090","article-title":"Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons","volume":"49","author":"Guillemin","year":"2005","journal-title":"Glia"},{"key":"10.1016\/j.bbih.2025.101149_bib38","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1523\/JNEUROSCI.19-07-02522.1999","article-title":"Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology","volume":"19","author":"Gutekunst","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbih.2025.101149_bib39","doi-asserted-by":"crossref","first-page":"8727","DOI":"10.1073\/pnas.96.15.8727","article-title":"Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity","volume":"96","author":"Hansson","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbih.2025.101149_bib40","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1523\/JNEUROSCI.09-02-00582.1989","article-title":"Neuropsychological evidence for multiple implicit memory systems: a comparison of Alzheimer's, Huntington's, and Parkinson's disease patients","volume":"9","author":"Heindel","year":"1989","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbih.2025.101149_bib41","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1093\/hmg\/11.26.3351","article-title":"Progressive retinal degeneration and dysfunction in R6 Huntington's disease mice","volume":"11","author":"Helmlinger","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbih.2025.101149_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/biom12070998","article-title":"The role of tryptophan dysmetabolism and quinolinic acid in depressive and neurodegenerative diseases","volume":"12","author":"Hestad","year":"2022","journal-title":"Biomolecules"},{"issue":"Pt 2","key":"10.1016\/j.bbih.2025.101149_bib43","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1042\/bj3260351","article-title":"Different kynurenine pathway enzymes limit quinolinic acid formation by various human cell types","volume":"326","author":"Heyes","year":"1997","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbih.2025.101149_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2005.01.024","article-title":"Early behavioral deficits in R6\/2 mice suitable for use in preclinical drug testing","volume":"20","author":"Hickey","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbih.2025.101149_bib45","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00702-024-02744-8","article-title":"Mild cognitive impairment in Huntington's disease: challenges and outlooks","volume":"131","author":"Jellinger","year":"2024","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.bbih.2025.101149_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113443","article-title":"Comparing HD knockin pigs and mice reveals the pathological role of IL-17","volume":"42","author":"Jia","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbih.2025.101149_bib47","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1365-2826.2007.01629.x","article-title":"Impaired glucose tolerance in the R6\/1 transgenic mouse model of Huntington's disease","volume":"20","author":"Josefsen","year":"2008","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.bbih.2025.101149_bib48","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0028-3932(91)90085-M","article-title":"Procedural learning is impaired in Huntington's disease: evidence from the serial reaction time task","volume":"29","author":"Knopman","year":"1991","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.bbih.2025.101149_bib49","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s00415-014-7319-6","article-title":"Cognitive and autonomic dysfunction in presymptomatic and early Huntington's disease","volume":"261","author":"Kobal","year":"2014","journal-title":"J. Neurol."},{"key":"10.1016\/j.bbih.2025.101149_bib50","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1073\/pnas.84.10.3491","article-title":"Quinolinic acid phosphoribosyltransferase: preferential glial localization in the rat brain visualized by immunocytochemistry","volume":"84","author":"Kohler","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbih.2025.101149_bib51","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1097\/00001756-199411000-00009","article-title":"Intrastriatal 3-nitropropionic acid: a behavioral assessment","volume":"5","author":"Koutouzis","year":"1994","journal-title":"Neuroreport"},{"key":"10.1016\/j.bbih.2025.101149_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147583","article-title":"Sex differences in circadian dysfunction in the BACHD mouse model of Huntington's Disease","volume":"11","author":"Kuljis","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bbih.2025.101149_bib53","doi-asserted-by":"crossref","DOI":"10.1111\/gbb.12633","article-title":"Age-related alteration of emotional regulation in the BACHD rat model of Huntington disease","volume":"19","author":"Lamirault","year":"2020","journal-title":"Gene Brain Behav."},{"key":"10.1016\/j.bbih.2025.101149_bib54","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1093\/hmg\/8.7.1227","article-title":"Ultrastructural localization and progressive formation of neuropil aggregates in Huntington's disease transgenic mice","volume":"8","author":"Li","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbih.2025.101149_bib55","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/hmg\/10.2.137","article-title":"Neurological abnormalities in a knock-in mouse model of Huntington's disease","volume":"10","author":"Lin","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbih.2025.101149_bib56","doi-asserted-by":"crossref","first-page":"10428","DOI":"10.1523\/JNEUROSCI.19-23-10428.1999","article-title":"Selective discrimination learning impairments in mice expressing the human Huntington's disease mutation","volume":"19","author":"Lione","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbih.2025.101149_bib57","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1093\/hmg\/ddl125","article-title":"Genetic background modifies nuclear mutant huntingtin accumulation and HD CAG repeat instability in Huntington's disease knock-in mice","volume":"15","author":"Lloret","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbih.2025.101149_bib58","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/104024","article-title":"Quinolinic acid: an endogenous neurotoxin with multiple targets","volume":"2013","author":"Lugo-Huitron","year":"2013","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.bbih.2025.101149_bib59","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bbih.2025.101149_bib114","doi-asserted-by":"crossref","first-page":"318","DOI":"10.2337\/db08-0799","article-title":"Exendin-4 improves glycemic control, ameliorates brain and pancreatic pathologies, and extends survival in a mouse model of Huntington\u2019s disease","volume":"58","author":"Martin","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.bbih.2025.101149_bib60","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.tins.2022.08.001","article-title":"How the immune system shapes neurodegenerative diseases","volume":"45","author":"Mason","year":"2022","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bbih.2025.101149_bib61","doi-asserted-by":"crossref","first-page":"9345","DOI":"10.1073\/pnas.0508875103","article-title":"Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington's disease","volume":"103","author":"McBride","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbih.2025.101149_bib62","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0165-6147(00)01884-8","article-title":"Mouse models of Huntington's disease","volume":"23","author":"Menalled","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbih.2025.101149_bib63","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/cne.10776","article-title":"Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats","volume":"465","author":"Menalled","year":"2003","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.bbih.2025.101149_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049838","article-title":"Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington's disease: zQ175","volume":"7","author":"Menalled","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbih.2025.101149_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008025","article-title":"Formation of polyglutamine inclusions in a wide range of non-CNS tissues in the HdhQ150 knock-in mouse model of Huntington's disease","volume":"4","author":"Moffitt","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.bbih.2025.101149_bib66","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0304-3940(84)90385-9","article-title":"The excitotoxin quinolinic acid is present in the brain of several mammals and its cortical content increases during the aging process","volume":"47","author":"Moroni","year":"1984","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbih.2025.101149_bib67","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1523\/JNEUROSCI.3842-04.2005","article-title":"Disintegration of the sleep-wake cycle and circadian timing in Huntington's disease","volume":"25","author":"Morton","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbih.2025.101149_bib68","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0304-3940(95)11311-J","article-title":"Chronically administered 3-nitropropionic acid induces striatal lesions attributed to dysfunction of the blood-brain barrier","volume":"186","author":"Nishino","year":"1995","journal-title":"Neurosci. Lett."},{"issue":"12","key":"10.1016\/j.bbih.2025.101149_bib69","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.3390\/biomedicines11123331","article-title":"Rodent models of Huntington's disease: an overview","volume":"11","author":"Nittari","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.bbih.2025.101149_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2020.112783","article-title":"Validation of behavioral phenotypes in the BACHD rat model","volume":"393","author":"Novati","year":"2020","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbih.2025.101149_bib71","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1523\/JNEUROSCI.16-09-03019.1996","article-title":"Chronic 3-nitropropionic acid treatment in baboons replicates the cognitive and motor deficits of Huntington's disease","volume":"16","author":"Palfi","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbih.2025.101149_bib72","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3389\/fnmol.2019.00258","article-title":"The role of microglia and astrocytes in Huntington's Disease","volume":"12","author":"Palpagama","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.bbih.2025.101149_bib73","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.bbr.2008.11.037","article-title":"Targeting oxidative\/nitrergic stress ameliorates motor impairment, and attenuates synaptic mitochondrial dysfunction and lipid peroxidation in two models of Huntington's disease","volume":"199","author":"Perez-De La Cruz","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbih.2025.101149_bib74","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-29792-x","article-title":"In vivo neutralization of the protagonist role of macrophages during the chronic inflammatory stage of Huntington's disease","volume":"8","author":"Pido-Lopez","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbih.2025.101149_bib75","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.expneurol.2010.03.009","article-title":"Acute intrastriatal administration of quinolinic acid provokes hyperphosphorylation of cytoskeletal intermediate filament proteins in astrocytes and neurons of rats","volume":"224","author":"Pierozan","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbih.2025.101149_bib76","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/nrn3570","article-title":"Choosing an animal model for the study of Huntington's disease","volume":"14","author":"Pouladi","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbih.2025.101149_bib77","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/ilar.48.4.356","article-title":"Animal models of Huntington's disease","volume":"48","author":"Ramaswamy","year":"2007","journal-title":"ILAR J."},{"key":"10.1016\/j.bbih.2025.101149_bib78","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2024.1384480","article-title":"Sex differences in Huntington's disease from a neuroinflammation perspective","volume":"15","author":"Risby-Jones","year":"2024","journal-title":"Front. Neurol."},{"key":"10.1016\/j.bbih.2025.101149_bib79","first-page":"137","article-title":"Behavioral and morphological comparison of two nonhuman primate models of Huntington's disease","volume":"50","author":"Roitberg","year":"2002","journal-title":"Neurosurgery"},{"key":"10.1016\/j.bbih.2025.101149_bib80","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0014-4886(89)90170-2","article-title":"The quinolinic acid model of Huntington's disease: locomotor abnormalities","volume":"105","author":"Sanberg","year":"1989","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbih.2025.101149_bib81","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.nbd.2008.09.017","article-title":"Use of magnetic resonance imaging for anatomical phenotyping of the R6\/2 mouse model of Huntington's disease","volume":"33","author":"Sawiak","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbih.2025.101149_bib82","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bbr.2003.10.021","article-title":"Progressive behavioural changes in the spatial open-field in the quinolinic acid rat model of Huntington's disease","volume":"152","author":"Scattoni","year":"2004","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbih.2025.101149_bib83","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/8.3.397","article-title":"Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin","volume":"8","author":"Schilling","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbih.2025.101149_bib84","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0304-3940(83)90115-5","article-title":"Differential vulnerability of central neurons of the rat to quinolinic acid","volume":"38","author":"Schwarcz","year":"1983","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbih.2025.101149_bib85","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0278-5846(98)00070-0","article-title":"Comparison of intrastriatal injections of quinolinic acid and 3-nitropropionic acid for use in animal models of Huntington's disease","volume":"22","author":"Shear","year":"1998","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbih.2025.101149_bib86","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1006\/exnr.1998.6767","article-title":"Chronic administration of quinolinic acid in the rat striatum causes spatial learning deficits in a radial arm water maze task","volume":"150","author":"Shear","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbih.2025.101149_bib87","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/hmg\/8.5.763","article-title":"A Huntington's disease CAG expansion at the murine Hdh locus is unstable and associated with behavioural abnormalities in mice","volume":"8","author":"Shelbourne","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbih.2025.101149_bib88","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.70217","article-title":"A novel and accurate full-length HTT mouse model for Huntington's disease","volume":"11","author":"Shenoy","year":"2022","journal-title":"eLife"},{"key":"10.1016\/j.bbih.2025.101149_bib89","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","article-title":"Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease","volume":"12","author":"Slow","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbih.2025.101149_bib90","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1523\/JNEUROSCI.4289-06.2007","article-title":"Endoplasmic reticulum stress inhibition protects against excitotoxic neuronal injury in the rat brain","volume":"27","author":"Sokka","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbih.2025.101149_bib91","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/hmg\/dds397","article-title":"A fully humanized transgenic mouse model of Huntington disease","volume":"22","author":"Southwell","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbih.2025.101149_bib92","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.nbd.2015.01.002","article-title":"Anti-semaphorin 4D immunotherapy ameliorates neuropathology and some cognitive impairment in the YAC128 mouse model of Huntington disease","volume":"76","author":"Southwell","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbih.2025.101149_bib93","first-page":"1115","article-title":"A novel humanized mouse model of Huntington disease for preclinical development of therapeutics targeting mutant huntingtin alleles","volume":"26","author":"Southwell","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbih.2025.101149_bib94","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/cne.20680","article-title":"Chronology of behavioral symptoms and neuropathological sequela in R6\/2 Huntington's disease transgenic mice","volume":"490","author":"Stack","year":"2005","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.bbih.2025.101149_bib95","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1038\/s41598-023-28798-4","article-title":"Beneficial behavioral effects of chronic cerebral dopamine neurotrophic factor (CDNF) infusion in the N171-82Q transgenic model of Huntington's disease","volume":"13","author":"Stepanova","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbih.2025.101149_bib96","doi-asserted-by":"crossref","first-page":"8093","DOI":"10.1073\/pnas.110078997","article-title":"Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease","volume":"97","author":"Turmaine","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbih.2025.101149_bib97","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1097\/00001756-200011270-00032","article-title":"N-Acetylaspartate and DARPP-32 levels decrease in the corpus striatum of Huntington's disease mice","volume":"11","author":"van Dellen","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.bbih.2025.101149_bib98","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1093\/hmg\/ddi407","article-title":"Selective degeneration and nuclear localization of mutant huntingtin in the YAC128 mouse model of Huntington disease","volume":"14","author":"Van Raamsdonk","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbih.2025.101149_bib99","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1523\/JNEUROSCI.0590-05.2005","article-title":"Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease","volume":"25","author":"Van Raamsdonk","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbih.2025.101149_bib100","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1093\/hmg\/ddl072","article-title":"Body weight is modulated by levels of full-length huntingtin","volume":"15","author":"Van Raamsdonk","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbih.2025.101149_bib101","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/ana.25647","article-title":"Early intrathecal T helper 17.1 cell activity in Huntington disease","volume":"87","author":"von Essen","year":"2020","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbih.2025.101149_bib102","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/hmg\/ddg075","article-title":"Transgenic rat model of Huntington's disease","volume":"12","author":"von Horsten","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbih.2025.101149_bib103","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1093\/hmg\/ddn175","article-title":"Accumulation of N-terminal mutant huntingtin in mouse and monkey models implicated as a pathogenic mechanism in Huntington's disease","volume":"17","author":"Wang","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbih.2025.101149_bib104","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1073\/pnas.1524575113","article-title":"Ablation of huntingtin in adult neurons is nondeleterious but its depletion in young mice causes acute pancreatitis","volume":"113","author":"Wang","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbih.2025.101149_bib105","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/hmg\/9.4.503","article-title":"Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice","volume":"9","author":"Wheeler","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbih.2025.101149_bib106","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0304-3940(83)90458-5","article-title":"Identification of quinolinic acid in rat and human brain tissue","volume":"41","author":"Wolfensberger","year":"1983","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbih.2025.101149_bib107","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.brainresbull.2006.11.004","article-title":"The Hdh(Q150\/Q150) knock-in mouse model of HD and the R6\/2 exon 1 model develop comparable and widespread molecular phenotypes","volume":"72","author":"Woodman","year":"2007","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.bbih.2025.101149_bib108","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/0092-8674(94)90557-6","article-title":"Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses","volume":"79","author":"Xu","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.bbih.2025.101149_bib109","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1523\/JNEUROSCI.23-06-02193.2003","article-title":"Mutant huntingtin causes context-dependent neurodegeneration in mice with Huntington's disease","volume":"23","author":"Yu","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbih.2025.101149_bib110","doi-asserted-by":"crossref","first-page":"13","DOI":"10.20517\/and.2024.13","article-title":"Advantages and differences among various animal models of Huntington's disease","volume":"4","author":"Yu","year":"2024","journal-title":"Ageing Neur Dis"},{"key":"10.1016\/j.bbih.2025.101149_bib111","doi-asserted-by":"crossref","first-page":"15426","DOI":"10.1523\/JNEUROSCI.1148-12.2012","article-title":"A novel BACHD transgenic rat exhibits characteristic neuropathological features of Huntington disease","volume":"32","author":"Yu-Taeger","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbih.2025.101149_bib112","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/ng1095-155","article-title":"Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue","volume":"11","author":"Zeitlin","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbih.2025.101149_bib113","article-title":"Abnormal brain development in Huntington' disease is recapitulated in the zQ175 Knock-In mouse model","volume":"1","author":"Zhang","year":"2020","journal-title":"Cereb Cortex Commun"}],"updated-by":[{"DOI":"10.1016\/j.bbih.2026.101180","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000}},{"DOI":"10.1016\/j.bbih.2026.101180","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000}}],"container-title":["Brain, Behavior, & Immunity - Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666354625002078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666354625002078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T08:10:05Z","timestamp":1774858205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666354625002078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":114,"alternative-id":["S2666354625002078"],"URL":"https:\/\/doi.org\/10.1016\/j.bbih.2025.101149","relation":{},"ISSN":["2666-3546"],"issn-type":[{"value":"2666-3546","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Animal models of Huntington's disease. Pros and cons","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, & Immunity - Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbih.2025.101149","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101149"}}